Scarica l'app Stockscreener
27.98
2.83%
0.77
Dopo l'orario di chiusura:
27.99
0.010
+0.04%
Precedente Chiudi:
$27.21
Aprire:
$27.37
Volume 24 ore:
2.34M
Relative Volume:
0.71
Capitalizzazione di mercato:
$2.24B
Reddito:
-
Utile/perdita netta:
$-96.66M
Rapporto P/E:
-13.01
EPS:
-2.15
Flusso di cassa netto:
$-83.73M
1 W Prestazione:
+0.11%
1M Prestazione:
+235.09%
6M Prestazione:
+527.35%
1 anno Prestazione:
+167.75%
Intervallo 1D:
$26.33
$28.82
Intervallo di 1 settimana:
$25.94
$28.82
Portata 52W:
$2.86
$29.51
Olema Pharmaceuticals Inc Stock (OLMA) Company Profile
Nome
Olema Pharmaceuticals Inc
Settore
Industria
Telefono
(415) 651-3316
Indirizzo
780 BRANNAN STREET, SAN FRANCISCO
Confronta OLMA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
27.98 | 2.18B | 0 | -96.66M | -83.73M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.04 | 115.56B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
703.26 | 75.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
430.02 | 60.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
900.76 | 55.48B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
196.55 | 43.51B | 447.02M | -1.18B | -906.14M | -6.1812 |
Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-08 | Iniziato | Guggenheim | Buy |
| 2025-08-12 | Reiterato | Citigroup | Buy |
| 2024-04-02 | Iniziato | Goldman | Buy |
| 2024-01-30 | Iniziato | Citigroup | Buy |
| 2023-07-21 | Iniziato | Oppenheimer | Outperform |
| 2023-05-05 | Iniziato | CapitalOne | Overweight |
| 2023-02-22 | Iniziato | Credit Suisse | Outperform |
| 2022-07-06 | Ripresa | Canaccord Genuity | Buy |
| 2022-06-09 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2022-02-28 | Iniziato | H.C. Wainwright | Neutral |
| 2021-12-07 | Ripresa | Cowen | Outperform |
| 2020-12-14 | Iniziato | Canaccord Genuity | Buy |
| 2020-12-14 | Iniziato | Cowen | Outperform |
| 2020-12-14 | Iniziato | JP Morgan | Overweight |
| 2020-12-14 | Iniziato | Jefferies | Buy |
Mostra tutto
Olema Pharmaceuticals Inc Borsa (OLMA) Ultime notizie
XTX Topco Ltd Makes New Investment in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Olema Pharmaceuticals, Inc. $OLMA Shares Bought by Schroder Investment Management Group - MarketBeat
Affinity Asset Advisors LLC Lowers Holdings in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Olema Pharmaceuticals (OLMA) price target increased by 53.92% to 37.23 - MSN
Olema Pharmaceuticals Inc Stock Analysis and ForecastVolume Profile Analysis & Turn Data into Profits With Our Strategies - earlytimes.in
Why Olema Pharmaceuticals Inc. stock is rated strong buyChart Signals & Capital Protection Trade Alerts - Newser
Why retail investors favor Olema Pharmaceuticals Inc. stockMarket Sentiment Review & Long-Term Growth Plans - Newser
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Caledonian Record
Olema Pharmaceuticals seeks senior medical director to advance oncology care - Traders Union
Olema Pharmaceuticals (OLMA) Stock Analysis Report | Financials & Insights - Benzinga
H.C. Wainwright Backs Olema Pharmaceuticals (OLMA) as Phase 3 Trials Advance - MSN
Olema Pharmaceuticals (OLMA): Assessing Valuation Following $190 Million Equity Offering and Underwriter Changes - Sahm
Olema Pharmaceuticals (NASDAQ:OLMA) Reaches New 1-Year HighHere's What Happened - MarketBeat
Will Olema Pharmaceuticals Inc. stock pay special dividends2025 Price Targets & Weekly Watchlist for Hot Stocks - BỘ NỘI VỤ
Olema Pharmaceuticals stock hits 52-week high at 27.25 USD By Investing.com - Investing.com Canada
Olema Pharmaceuticals stock hits 52-week high at 27.25 USD - Investing.com
15,000 Shares in Olema Pharmaceuticals, Inc. $OLMA Bought by Titleist Asset Management LLC - MarketBeat
Olema Pharmaceuticals : Statement of Changes in Beneficial Ownership (Form 4) - marketscreener.com
Dir Rappaport Acquires 35,868 Of Olema Pharmaceuticals Inc [OLMA] - TradingView
[Form 4] Olema Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan
Olema Pharmaceuticals Reports Increased Losses Amid R&D Expansion - MSN
Olema Pharmaceuticals (OLMA): Evaluating the Current Valuation After a Strong Run-Up in Recent Months - Yahoo Finance
Goldman Sachs Raises Stake in Olema Pharmaceuticals, Inc. (OLMA) - MSN
LifeSci Capital Reaffirms Their Buy Rating on Olema Pharmaceuticals (OLMA) - The Globe and Mail
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
The Goldman Sachs Group Boosts Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $26.00 - MarketBeat
Olema Oncology to Participate in Upcoming Investor Conferences - Sahm
Research Analysts Set Expectations for OLMA Q1 Earnings - MarketBeat
Goldman Sachs Maintains Olema Pharmaceuticals (OLMA) Buy Recommendation - MSN
Olema Pharmaceuticals Inc. (OLMA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Olema Oncology to Participate in 8th Annual Evercore Healthcare Conference - The Manila Times
Small Cap Stocks To Keep An Eye OnNovember 18th - MarketBeat
Goldman Sachs Raises Price Target for Olema Pharmaceuticals (OLM - GuruFocus
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Up 26%What's Next? - MarketBeat
Commit To Purchase Olema Pharmaceuticals At $16, Earn 40.4% Annualized Using Options - Nasdaq
Olema Oncology Announces Closing of $218.5 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares - The Manila Times
Olema Pharmaceuticals Closes $218.5 Million Public Offering of Common Stock - Quiver Quantitative
Olema Oncology (Nasdaq: OLMA) Completes $218.5M Equity Sale at $19 Per Share - Stock Titan
Olema Pharmaceuticals (NASDAQ:OLMA) Sees Unusually-High Trading Volume Following Analyst Upgrade - MarketBeat
Olema Pharmaceuticals Oncology Announces Pricing of $190.0 Million Public Offering of Common Stock - MarketScreener
What technical signals suggest for Olema Pharmaceuticals Inc. stockStop Loss & Momentum Based Trading Signals - newser.com
Why Olema Pharmaceuticals Inc. stock is in analyst buy zoneProfit Target & AI Based Trade Execution Alerts - newser.com
Will Olema Pharmaceuticals Inc. continue its uptrendIPO Watch & Short-Term Swing Trade Alerts - newser.com
Potential Buying Opportunity for OLMA? - StocksToTrade
Is Olema Pharmaceuticals Inc. stock attractive for passive investorsWeekly Investment Report & Precise Swing Trade Entry Alerts - newser.com
Olema Pharmaceuticals Announces Public Stock Offering - TipRanks
Olema Pharmaceuticals Announces Follow-On Public Offering - TradingView
[8-K] Olema Pharmaceuticals, Inc. Reports Material Event | OLMA SEC FilingForm 8-K - Stock Titan
Forecasting Olema Pharmaceuticals Inc. price range with options data2025 Volatility Report & Free Weekly Watchlist of Top Performers - newser.com
What Fibonacci levels say about Olema Pharmaceuticals Inc. rebound2025 Year in Review & Low Risk High Reward Trade Ideas - newser.com
Olema Pharmaceuticals Terminates ATM Prospectus - MSN
Olema Pharmaceuticals Inc Azioni (OLMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.67%
0.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):